Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
80018273
Market status:
Marketed
Licence Status:
Active
Brand name(s):
A. Vogel Echinaforce Junior
Licence holder:
Bioforce Canada Inc.
Dosage Form:
Tablet
Recommended route of administration:

Oral

Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Children 2 4 year(s) 1.0 tablet 1 daily
Children 2 4 year(s) 1.0 tablet 1 2 daily
Children and Adolescents 5 9 year(s) 1.0 tablet 2 3 daily
Children and Adolescents 5 9 year(s) 1.0 tablet 2 daily
Recommended use or purpose:
Clinically shown to help prevent and relieve the symptoms of viral respiratory tract infections such as the common cold and flu. Shortens the duration of upper respiratory tract infections. Used in Herbal Medicine to support the immune system, especially in times of stress and lack of sleep. Take at the first sign of infection.
Risk Information:
Cautions and Warnings 
If symptoms persist or worsen, consult a health care practitioner. If you are taking immunosuppressants,consult a health care practitioner prior to use. If you have an autoimmune disorder consult a health carepractitioner prior to use. If you have a progressive systemic disease, such as tuberculosis, collagenosis,multiple sclerosis, AIDS and / or HIV infection, consult a health care practitioner prior to use. Stop use ifhypersensitivity/allergy occurs.
Contra-Indications 
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
Known Adverse Reactions 
Stop use if hypersensitivity/allergy occurs.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Echinacea purpurea 6.35 mg
5 : 1
DHE: 31.7 mg
380.0   mg
Tincture
Echinacea purpurea 0.33 mg
5.5 : 1
DHE: 1.8 mg
20.0   mg
Tincture
List of non-medicinal ingredients:
  • Beta-cyclodextrin, natural form
  • Colloidal silicon dioxide
  • Magnesium Stearate
  • Natural orange flavour
  • Sorbitol
Date of licensing:
2010-05-03
Revised date of licence:
2025-03-26

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

"Page details"

Date modified: